Emcure cuts GLP drug Poviztra price by 55% Emcure Pharmaceuticals has announced a massive 55% price cut for Poviztra, its semaglutide weight-management drug in India. April 3, 2026 01:15 IST
₹1,000 cr to ₹5,000 cr: 3 pharma stocks to watch for India’s GLP-1 explosion by 2030 A ₹1,000 crore market is set to grow 5x to ₹5,000 crore by 2030 as prices drop 40–50% post patent… March 31, 2026 05:27 IST
Not just Ozempic: Biocon shares in focus after USFDA clears GLP-1 Liraglutide injection – What it means Biocon earns USFDA nod for Liraglutide injection, boosting its diabetes drug portfolio. Explore investment opportunities now! March 13, 2026 06:58 IST
Why Serena Williams is facing backlash for promoting a GLP-1 weight-loss drug during the Super Bowl Serena Williams’ Super Bowl ad promoting a GLP-1 weight-loss drug sparks backlash, raising concerns over celebrity endorsements, Big Pharma influence,… Updated: February 10, 2026 11:42 IST
Wegovy weight loss pill is now available in the US: Check out its surprisingly low price Novo Nordisk has launched the first once-daily oral version of its blockbuster weight loss drug Wegovy in the US, priced… Updated: January 11, 2026 08:23 IST
WHO issues first-ever global guideline on GLP-1 weight-loss drugs to address the obesity crisis WHO has issued its first global guideline supporting the use of GLP-1 weight-loss medicines for long-term obesity care, calling obesity… Updated: January 11, 2026 08:34 IST
Big boost for Mumbaikers: New Suburban Railway Station planned between Thane and Mulund to ease rush in Mumbai local trains
iPhone 17, iPhone 17 Pro, iPhone 17 Pro Max prices in India, UAE, US, Canada, Singapore, Australia in May 2026